Tuerksever, Cengiz
Pruente, Christian
Hatz, Katja
Article History
Received: 12 November 2020
Accepted: 11 March 2021
First Online: 25 March 2021
Competing interests
: Professor Pruente and PD Dr Hatz independently have received financial compensation from Novartis Switzerland, Bayer Switzerland, Alcon, Allergan and Roche for consultancies and contract research. Dr Tuerksever declares no conflict of interest in relation to the manuscript.